ClinicalTrials.Veeva

Menu

Pilot Study: Age Extension of NHS Breast Screening Programme

University of Oxford logo

University of Oxford

Status

Completed

Conditions

Routine Mammography

Treatments

Other: Invitation for breast screening

Study type

Interventional

Funder types

Other

Identifiers

NCT00890864
ISRCTN50037017
09/H0710/2

Details and patient eligibility

About

The purpose of this pilot study is to assess the feasibility and acceptability of randomising the phasing-in of the age extension of the NHS Breast Screening Programme in six volunteer sites in different areas of England.

Full description

Currently all women are invited for breast screening between the ages of 50 and 70. In 2007 the Cancer Reform Strategy announced that from 2012 the NHS Breast Screening Programme would be extended to cover women between the ages of 47 and 73. This means that all women will get two extra screening invitations in their lifetime. It also means that all women will get their first invitation before age 50. As capacity does not allow for full immediate roll out across the whole of England, the age extension will be phased-in with full coverage from 2012. Randomising this phasing-in would provide unbiased evidence on the extent to which it is beneficial to extend the age range for breast screening and whether an extra screen at younger or older ages is more worthwhile. To date there is no clear evidence on this as no trial has looked at the added value of one extra screen within an existing screening programme. This pilot study will assess the feasibility and acceptability of randomising the phasing-in of the age extension in six volunteer sites in different areas of England.

Enrollment

36,000 estimated patients

Sex

Female

Ages

47 to 73 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • female, and living in one of the 6 pilot areas, and
  • aged 47-49 or 71-73 years, and
  • in a screening invitation batch that includes their age group.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

36,000 participants in 2 patient groups

1
Active Comparator group
Description:
Women aged 47-49 invited for breast screening
Treatment:
Other: Invitation for breast screening
2
Active Comparator group
Description:
Women aged 71-73 invited for breast screening
Treatment:
Other: Invitation for breast screening

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems